Lonza/Moderna will expand covid-19 vaccine raw material drug production cooperation
Lonza Group (Lonza Group) said on Wednesday that the company will further cooperate with Moderna Inc. (MRNA) to expand the production of raw materials required for the new crown vaccine produced by the US biotechnology company.
The Swiss life sciences company said that under this agreement, Lonza Group will install a new production line in Geleen, the Netherlands, which will help to supply up to 300 million additional doses of Moderna vaccine each year. The Lonza Group stated that this new production line should begin operation before the end of this year.
Lonza Group stated that in May 2020, the company had announced a ten-year strategic cooperation agreement with Moderna to enable the production of Moderna's new crown vaccine and other Moderna products in the future. Lonza Group said that since last May, the company has installed several production lines in Switzerland and the United States.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lonza acquires Roche US biologics facility for $1.2 billion
-
Lonza Launches Innovaform Accelerator
-
Lonza acquires biologics plant from Roche for $1.2 billion
-
Moderna's Financial Challenges: A Shift from COVID-19 Vaccine Revenue
-
CXO is unyielding!
-
How Many Covid Vaccines Are Made Per Hour
-
Takeda Refunds Japan Rights to Moderna's COVID-19 Vaccine Spikevax
-
CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List
-
2 Covid-19 Vaccines have been Approved for Marketing, What is the Future Prospect of mRNA Vaccines?
-
Pharmaceutical companies might have there been other mrna vaccines and strategies to deal with covid-19
Recommend Reading
-
![Nouryon Opens New Customer Experience and Innovation Center in Brazil]()
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
![“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?]()
“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?
-
![“Amputate to Survive, or Bleed to Feed the Vultures?”: Dow’s 4,500 Layoffs Reveal the Life-or-Death Battle in Global Chemicals]()
“Amputate to Survive, or Bleed to Feed the Vultures?”: Dow’s 4,500 Layoffs Reveal the Life-or-Death Battle in Global Chemicals
-
![Dow Q3 2025: Struggling at the Bottom of the Cycle Amid a Slow Structural Recovery]()
Dow Q3 2025: Struggling at the Bottom of the Cycle Amid a Slow Structural Recovery
-
![Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan]()
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
![From Scale Expansion to Technology Premium: The Shifting Landscape of the Acrylic Market 2025-2026]()
From Scale Expansion to Technology Premium: The Shifting Landscape of the Acrylic Market 2025-2026
-
![Geopolitical Premium Fades & Supply Easing Expectations Lead to Sharp Drop in Oil Prices]()
Geopolitical Premium Fades & Supply Easing Expectations Lead to Sharp Drop in Oil Prices
-
![Phthalic Anhydride Prices Rebound and Rise in China]()
Phthalic Anhydride Prices Rebound and Rise in China
-
![January Petrocoke Market Trends: First Rise, Then Fall]()
January Petrocoke Market Trends: First Rise, Then Fall
-
![Entering December, the domestic maleic anhydride market in China continues to decline]()
Entering December, the domestic maleic anhydride market in China continues to decline
